VT ART Consortium: Radioablation for Ventricular Tachycardia
Key facts
- Who runs it
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 52 people, planned
- Started
- 26 Nov 2024
- Expected to end
- 31 Oct 2029
- Type of study
- Interventional
- Treatments tested
- Stereotactic Body Radiation Therapy (SBRT)
- Record updated
- 11 May 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- Patients with refractory VT
- age > 18 years
- Patients with ICDs for follow-up
- Ineligible for heart transplantation
- Prognosis of not less than 1 year
- Ability to express autonomous consent to therapies or (in case of inability due to clinical condition) deferred consent (first indicated by the referring clinician, later expressed by the patient once recovered to autonomous condition
Who cannot take part
- Patients with active neoplastic disease undergoing oncological treatment
- Evaluation of ICD demonstrating polymorphic VT
- Patients with INTERMACS class greater than 4
- Patients with LVAD
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The overall objective of the study is to evaluate the efficacy and safety of stereotactic radiation therapy in the non invasive ablation of ventricular tachycardia refractory to any other type treatment.
The group in the trial
- Refractory ventricular tachycardia patientsTreatment being tested
Patients with refractory VT as defined above 1. age \> 18 years 2. ICD patients for follow-up 3. Not eligible for heart transplantation. 4. Prognosis not less than 1 year. They will have an initial assessment to verify that condition met the inclusion criteria required for participation, such as.It will be performed * 12-lead ECG * Echocardiography * CT scan of the chest * Laboratory analysis: NT proBNP, HS Troponin I * PMK device evaluation and clinical ECG storage. They will undergo stereotactic treatment on the arrhythmogenic cardiac site
Treatment: Stereotactic Body Radiation Therapy (SBRT)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- VT-ART-P: Ventricular Tachycardia Ablation and RadioTherapy, a Prospective Study
- Record updated
- 11 May 2025